StockDuty ← Dashboard Sep 08, 2026 01:59 PM ET
CatalystCorporate

NANOVIRICIDES : CLINICAL TRIAL FOR AN ORAL DRUG TO TREAT EBOLA IS REGISTERED IN THE PAN AFRICAN CLINICAL TRIALS DATABASE AND IS READY TO GO , AS THE LARGEST EBOLA OUTBREAK CONTINUES TO EXPAND IN DR CO

Ebola outbreak expansion plus registered oral drug trial signals major therapeutic progress.

Ebola outbreak expansion plus registered oral drug trial signals major therapeutic progress.
Ebola outbreak expansion plus registered oral drug trial signals major therapeutic progress. — impact context not separately stored; see What changed.
Sources